Kiyoshi Nakamatsu - Search Results

Year	Number of Results
2002	1
2003	4
2004	3
2005	1
2006	1
2008	3
2009	2
2010	4
2011	2
2012	1
2013	1
2014	4
2015	1
2016	1
2017	2
2018	6
2019	5
2020	4
2021	8
2022	7
2023	6
2024	0

1

Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a review.

Doi H, Nakamatsu K, Nishimura Y. Doi H, et al. Among authors: nakamatsu k. Int J Clin Oncol. 2019 Aug;24(8):899-909. doi: 10.1007/s10147-019-01432-y. Epub 2019 Apr 1. Int J Clin Oncol. 2019. PMID: 30937620 Review.

2

Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer.

Kishi N, Matsuo Y, Shintani T, Ogura M, Mitsuyoshi T, Araki N, Fujii K, Okumura S, Nakamatsu K, Kishi T, Atsuta T, Sakamoto T, Ohtsu S, Katagiri T, Narabayashi M, Fujishiro S, Iizuka Y, Ozasa H, Hirai T, Mizowaki T; Kyoto Radiation Oncology Study Group (KROSG). Kishi N, et al. Among authors: nakamatsu k. J Radiat Res. 2023 Jan 20;64(1):142-153. doi: 10.1093/jrr/rrac057. J Radiat Res. 2023. PMID: 36149029 Free PMC article.

3

Risk factors for radiation pneumonitis after rotating gantry intensity-modulated radiation therapy for lung cancer.

Tatsuno S, Doi H, Okada W, Inoue E, Nakamatsu K, Tanooka M, Tanaka M, Nishimura Y. Tatsuno S, et al. Among authors: nakamatsu k. Sci Rep. 2022 Jan 12;12(1):590. doi: 10.1038/s41598-021-04601-0. Sci Rep. 2022. PMID: 35022506 Free PMC article.

4

Definitive chemoradiotherapy for anal canal cancer: single-center experience.

Tachibana I, Nishimura Y, Inada M, Fukuda K, Ishikawa K, Nishikawa T, Yokokawa M, Nakamatsu K, Kanamori S, Hida JI. Tachibana I, et al. Among authors: nakamatsu k. Int J Clin Oncol. 2018 Dec;23(6):1121-1126. doi: 10.1007/s10147-018-1316-1. Epub 2018 Jul 10. Int J Clin Oncol. 2018. PMID: 29992389

5

Clinical course of longer than five years after definitive radiotherapy for nasopharyngeal carcinoma.

Doi H, Ri A, Inada M, Tatsuno S, Uehara T, Matsuura T, Ishikawa K, Nakamatsu K, Hosono M, Nishimura Y. Doi H, et al. Among authors: nakamatsu k. Int J Clin Oncol. 2023 Dec;28(12):1607-1615. doi: 10.1007/s10147-023-02418-7. Epub 2023 Oct 5. Int J Clin Oncol. 2023. PMID: 37798414

6

Multi-institutional feasibility study of intensity-modulated radiotherapy with chemotherapy for locally advanced non-small cell lung cancer.

Harada H, Omori S, Mori K, Konno M, Murakami H, Imagumbai T, Fukuda H, Nakamatsu K, Kimura T, Tanabe H, Fujita H, Tatebe H, Fujitaka K, Nishimura Y. Harada H, et al. Among authors: nakamatsu k. Int J Clin Oncol. 2022 Jun;27(6):1025-1033. doi: 10.1007/s10147-022-02151-7. Epub 2022 Mar 19. Int J Clin Oncol. 2022. PMID: 35305192

7

Difference in VMAT dose distribution for prostate cancer with/without rectal gas removal and/or adaptive replanning.

Wada Y, Monzen H, Otsuka M, Doi H, Nakamatsu K, Nishimura Y. Wada Y, et al. Among authors: nakamatsu k. Med Dosim. 2022 Spring;47(1):87-91. doi: 10.1016/j.meddos.2021.09.002. Epub 2021 Oct 24. Med Dosim. 2022. PMID: 34702634

8

Multi-institution model (big model) versus single-institution model of knowledge-based volumetric modulated arc therapy (VMAT) planning for prostate cancer.

Fukunaga JI, Tamura M, Ueda Y, Kamima T, Shimizu Y, Muraki Y, Nakamatsu K, Monzen H. Fukunaga JI, et al. Among authors: nakamatsu k. Sci Rep. 2022 Sep 10;12(1):15282. doi: 10.1038/s41598-022-19498-6. Sci Rep. 2022. PMID: 36088382 Free PMC article.

9

Visualization of tumor hypoxia and re-oxygenation after stereotactic body radiation therapy in early peripheral lung cancer: A prospective study.

Inada M, Nishimura Y, Hanaoka K, Nakamatsu K, Doi H, Uehara T, Komanishi M, Ishii K, Kaida H, Hosono M. Inada M, et al. Among authors: nakamatsu k. Radiother Oncol. 2023 Mar;180:109491. doi: 10.1016/j.radonc.2023.109491. Epub 2023 Jan 24. Radiother Oncol. 2023. PMID: 36706956 Free article.

10

Experimental Animal Model of Re-irradiation to Evaluate Radiation-induced Damage in the Normal Intestine.

Doi H, Tamura M, Nakamatsu K, Monzen H, Nishimura Y. Doi H, et al. Among authors: nakamatsu k. Anticancer Res. 2020 Apr;40(4):1981-1988. doi: 10.21873/anticanres.14153. Anticancer Res. 2020. PMID: 32234887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

61 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year